Skip to content
BioNews Central
  • Home
  • Biomedical Advances
  • Diet & Lifestyle
  • Preventive Medicine
  • COVID-19
  • Quizzes

Posts by Dana-Farber Cancer Institute

New evidence of health threat from chemicals in marijuana and tobacco smoke

Dana-Farber Cancer Institute | 01-11-2021

Scientists have uncovered new evidence of the potential health risks of chemicals in marijuana and tobacco smoke. …

Read Full Article

CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

Dana-Farber Cancer Institute | 12-05-2020

A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma …

Read Full Article

Inherited pancreatic cancer risk mutation identified

Dana-Farber Cancer Institute | 08-12-2019

Scientists studying a highly cancer-prone family have identified a rare, inherited gene mutation that dramatically raises the lifetime risk of pancreatic and other cancers. …

Read Full Article

Chemotherapy drug found to spur immune system attack on lymphoma

Dana-Farber Cancer Institute | 07-01-2019

Researchers demonstrate that large doses of cyclophosphamide not only kill cancer cells directly, as has been known, but also spur an immune system attack on the cells. …

Read Full Article

Targeted therapy proves effective against aggressive rare blood cancer

Dana-Farber Cancer Institute | 04-24-2019

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN). …

Read Full Article

Drug combination may become new standard treatment for advanced kidney cancer

Dana-Farber Cancer Institute | 02-16-2019

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, …

Read Full Article

After 60 years, scientists uncover how thalidomide produced birth defects

Dana-Farber Cancer Institute | 08-01-2018

More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent …

Read Full Article

Blood test shows potential for early detection of lung cancer

Dana-Farber Cancer Institute | 06-02-2018

A test that analyzes free-floating DNA in the blood may be able to detect early-stage lung cancer, a preliminary report from the ongoing Circulating Cell-Free Genome Atlas (CCGA) study suggests. …

Read Full Article

Popular Tags

aging alzheimer's disease brain and cognitive health cancer cardiovascular disease coronavirus COVID-19 diabetes diet immune cells immune response immune system inflammation microbiome mouse study neurons obesity SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cells

About           Terms          Copyright          Privacy          Contact

About

Terms

Copyright

Privacy

Contact

© 2021 BioNews Central  |  Bright Quest Media  |  All Rights Reserved

Scroll To Top